Connect with us

Marijuana Movement

New Cannabis Breed Made by Chiang Mai University in Thailand, a First-Ever for ASEAN Countries

Published

on

New Cannabis Breed Made by Chiang Mai University in Thailand, a First-Ever for ASEAN Countries
  • Thailand is the first country in ASEAN to create an original breed of medical cannabis.
  • Deputy Prime Minister Anutin Charnvirakul stated that the University is working to make it possible for households to grow six of their own medical cannabis plants.

Medical cannabis has been rising in popularity in Thailand recently, and the Maejo University in Chiang Mai province has decided to capitalize on this progress. According to Asia One, the university has officially developed the first industrial grade medical cannabis with a Thailand-originated breed. Deputy Prime Minister and Minister of Public Health Anutin Charnvirakul stated on Saturday that Thailand is officially the first country in ASEAN to create its own breed of cannabis for medical use.

The announcement by Charnvirakul was released during a visit to the Natural Agriculture Research and Development Centre of the University. He stated:

“This project is a collaboration between Maejo University, the Government Pharmaceutical Organization (GPO), and the Department of Medical Services since June.”

He added that the GPO should expect a delivery of 2.4 tonnes of dried cannabis from these crops, which will be used in the production of cannabis-based drugs by February 2020.

Outdoor growing techniques have been a priority of Maejo University recently, utilizing organic materials and pesticides that can be adapted to other operations in the future. Charnvirakul expressed that the University is working to “perfect a technique” that makes it possible for the average household to grow six cannabis plants on their own property for medical purposes. He added that the new breed from Maejo “is strong and of high quality,” providing users with a balance of CBD and THC.

Professor Dr. Anat Tancho, the director of Natural Agriculture Research and Development Centre, pointed out that Maejo University works to develop a healthy growing environment for their medical cannabis. In doing so, they promote better breeding and increase the quality of medical cannabis. Dr. Tancho stated:

“We follow the standards of IFOAM [International Federation of Organic Agriculture Movements] and USDA [United States Department of Agriculture] organic standard,” he said. “Moreover, since marijuana is still a narcotic plant, we also strictly adhere to the GSP [Good Security Practices] to ensure full compliance with the law.”

Judith Hayes lives in Maine and loves to visit Florida. She is a women of many talents and skills as her primary passion is freelance writing but is also a web designer, photographer and world traveller. Her experience in broadcast journalism is what led her into authoring several books as well as being a featured editor at the Journal of Health magazine. Judith enjoys writing about health, nutrition, vegetarianism, aging, lifestyle, technology and of course, cannabis and CBD.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.